These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C. Langhans B, Braunschweiger I, Arndt S, Schulte W, Satoguina J, Layland LE, Vidovic N, Hoerauf A, Oldenburg J, Sauerbruch T, Spengler U. Clin Sci (Lond); 2010 Apr 20; 119(2):97-109. PubMed ID: 20222873 [Abstract] [Full Text] [Related]
7. Functional suppression by FoxP3+CD4+CD25(high) regulatory T cells during acute hepatitis C virus infection. Smyk-Pearson S, Golden-Mason L, Klarquist J, Burton JR, Tester IA, Wang CC, Culbertson N, Vandenbark AA, Rosen HR. J Infect Dis; 2008 Jan 01; 197(1):46-57. PubMed ID: 18171284 [Abstract] [Full Text] [Related]
8. Elevated CD4+/CD25+ T-cell frequency and function during hepatitis C virus recurrence after liver transplantation. Perrella A, Arenga G, Pisaniello D, Rampone B, Di Costanzo GG, Atripaldi L, Esposito C, Di Florio E, Perrella O, Cuomo O. Transplant Proc; 2009 Jun 01; 41(5):1761-6. PubMed ID: 19545723 [Abstract] [Full Text] [Related]
9. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages. Rosen HR, Miner C, Sasaki AW, Lewinsohn DM, Conrad AJ, Bakke A, Bouwer HG, Hinrichs DJ. Hepatology; 2002 Jan 01; 35(1):190-8. PubMed ID: 11786976 [Abstract] [Full Text] [Related]
15. A novel assay for detection of hepatitis C virus-specific effector CD4(+) T cells via co-expression of CD25 and CD134. Keoshkerian E, Helbig K, Beard M, Zaunders J, Seddiki N, Kelleher A, Hampartzoumian T, Zekry A, Lloyd AR. J Immunol Methods; 2012 Jan 31; 375(1-2):148-58. PubMed ID: 22019644 [Abstract] [Full Text] [Related]
16. Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort. Post JJ, Pan Y, Freeman AJ, Harvey CE, White PA, Palladinetti P, Haber PS, Marinos G, Levy MH, Kaldor JM, Dolan KA, Ffrench RA, Lloyd AR, Rawlinson WD, Hepatitis C Incidence and Transmission in Prisons Study (HITS) Group. J Infect Dis; 2004 May 15; 189(10):1846-55. PubMed ID: 15122521 [Abstract] [Full Text] [Related]
17. Prospective study of viral clearance and CD4(+) T-cell response in acute hepatitis C primary infection and reinfection. Aberle JH, Formann E, Steindl-Munda P, Weseslindtner L, Gurguta C, Perstinger G, Grilnberger E, Laferl H, Dienes HP, Popow-Kraupp T, Ferenci P, Holzmann H. J Clin Virol; 2006 May 15; 36(1):24-31. PubMed ID: 16483838 [Abstract] [Full Text] [Related]
18. Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection. Semmo N, Krashias G, Willberg C, Klenerman P. J Viral Hepat; 2007 Jul 15; 14(7):492-502. PubMed ID: 17576391 [Abstract] [Full Text] [Related]
19. Hepatitis C virus core protein triggers expansion and activation of CD4(+)CD25(+) regulatory T cells in chronic hepatitis C patients. Zhai N, Chi X, Li T, Song H, Li H, Jin X, Crispe IN, Su L, Niu J, Tu Z. Cell Mol Immunol; 2015 Nov 15; 12(6):743-9. PubMed ID: 25531392 [Abstract] [Full Text] [Related]
20. Hepatitis C virus-specific reactivity of CD4+-lymphocytes in children born from HCV-infected women. Della Bella S, Riva A, Tanzi E, Nicola S, Amendola A, Vecchi L, Nebbia G, Longhi R, Zanetti AR, Villa ML. J Hepatol; 2005 Sep 15; 43(3):394-402. PubMed ID: 16023248 [Abstract] [Full Text] [Related] Page: [Next] [New Search]